📰 Ian Mortimer News
Ian Mortimer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ian Mortimer. Real-time updates on events, politics, business and more.
June 5, 2024
05.06.2024 - VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global ...
May 28, 2024
VANCOUVER, British Columbia, May 28, 2024 -- Xenon Pharmaceuticals Inc. , a neuroscience-focused biopharmaceutical company, announced data presentations highlighting azetukalner clinical data in...
April 10, 2024
VANCOUVER, British Columbia, April 10, 2024 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton &...
February 21, 2024
There was more to the period than violence, superstition and ignorance, argues a new book | Culture
January 3, 2024
VANCOUVER, British Columbia, Jan. 03, 2024 -- Xenon Pharmaceuticals Inc. , a neurology-focused biopharmaceutical company, today announced that the company will present at the 42nd Annual J.P....
December 18, 2023
As contentious statues are removed around the world, our understanding of the events which shaped our holiday spots dwindles
December 17, 2023
The past doesn’t produce itself. It is recreated — refracted — by those living in the present. And those who bother to direct so much energy into something as abstract as what no longer exists, into what has slipped through the fingers of time, are unlikely to be impartial actors, impervious to the zeitgeist of their age. Politicians, novelists and filmmakers would be the first to admit (well, the latter two at least) that the act of historical resurrection is a creative, so...
December 10, 2023
The fund has an excellent record. Since 2011, there has only been one year - 2020 - when the managers have not been able to furnish investors with growing dividends.
December 9, 2023
The fund has an excellent record. Since 2011, there has only been one year - 2020 - when the managers have not been able to furnish investors with growing dividends.
December 4, 2023
Company co-founded by renowned geneticist Michael Hayden building franchise around treatment discovered by Valeant